← All organizations
Highest phase reached
Phase 4
First clinical trial
May 16, 2017Last known activity
Sep 30, 2024
Timeline
2000s
- Jan 1, 2007
Region of Southern Denmark— Founded
Drugs by trial phase (13 distinct, 10 trials)
Phase 4 (6 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Recent trials (10)
- NCT06473701CollaboratorPhase 3Sep 30, 2024
- NCT06476392CollaboratorPhase 3Sep 1, 2024
- NCT04924270CollaboratorPhase 2Jan 31, 2022
- NCT05193578CollaboratorPhase 2Jan 12, 2022
- NCT05052125CollaboratorPhase 4Sep 30, 2021
- NCT04318067Sponsor investigatorPhase 4Sep 30, 2020
- NCT03778554CollaboratorPhase 4Dec 17, 2018
- NCT03847545CollaboratorN/ADec 12, 2018
- NCT03425084CollaboratorPhase 1Mar 1, 2018
- NCT03058900CollaboratorN/AMay 16, 2017
Details
- Founded
- Vejle, DK Jan 1, 2007
- Last known activity
- Sep 30, 2024